Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2020
Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-yearsAnnie Hawton, Elizabeth Goodwin, Kate Boddy, et al.
Pharmacology Research & Perspectives|October 22, 2020
Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacortRonald Kong, Jiyuan Ma, Brian Beers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 26, 2020
Metabolism and Disposition of Ataluren after Oral Administration to Mice, Rats, Dogs, and HumansRonald Kong, Jiyuan Ma, Seongwoo Hwang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2025
Comparative Responsiveness of Preference-Based Health-Related Quality of Life, Social Care, and Well-Being Measures in the Context of Multiple SclerosisElizabeth Goodwin, Amy Heather, Nia Morrish, et al.
COPD|March 11, 2010
The safety and efficacy of arformoterol and formoterol in COPDNicola A Hanania, James F Donohue, Harold Nelson, et al.
The Journal of Allergy and Clinical Immunology|August 12, 2008
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjectsKenneth Tripp, William K McVicar, Parameswaran Nair, et al.
RNA Biology|January 18, 2013
Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cellsSudha Talwar, Sundaravadivel Balasubramanian, Santhanalakshmi Sundaramurthy, et al.
Pharmacology Research & Perspectives|March 21, 2020
In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of atalurenRonald Kong, Jiyuan Ma, Seongwoo Hwang, et al.
BMC Musculoskeletal Disorders|May 3, 2023
CycLing and EducATion (CLEAT): protocol for a single centre randomised controlled trial of a cycling and education intervention versus standard physiotherapy care for the treatment of hip osteoarthritisThomas W Wainwright, Erika P Parkinson, Tikki Immins, et al.
The Lancet. Rheumatology|August 3, 2025
Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trialThomas W Wainwright, Tikki Immins, Sharon Docherty, et al.
Pageof 5